Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals Approved Scheme Of Amalgamation Of Cohance Lifesciences Into And With Co

Feb 29 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * SUVEN PHARMACEUTICALS LTD -  APPROVED SCHEME OF
AMALGAMATION OF
COHANCE LIFESCIENCES INTO AND WITH CO

Source text for Eikon:  ID:nBSE3fxld6 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Cohance Lifesciences

See all news